High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer
about
Leucine-rich repeat, immunoglobulin-like and transmembrane domain 3 (LRIT3) is a modulator of FGFR1High-resolution genomic profiles of human lung cancerTRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancerFunctional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancersTargeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyondInhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical applicationRCP is a human breast cancer-promoting gene with Ras-activating functionLaminin-binding integrin gene copy number alterations in distinct epithelial-type cancersPrognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancerThe unique expression and function of miR-424 in human placental trophoblasts.Genetic alterations of chromosome 8 genes in oral cancer.Selection of microsatellite markers for bladder cancer diagnosis without the need for corresponding blood.Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reactionFGFR1 amplifications in squamous cell carcinomas of the lung: diagnostic and therapeutic implications.The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy.Fibroblast growth factor receptor 1 promotes MG63 cell proliferation and is associated with increased expression of cyclin-dependent kinase 1 in osteosarcomaDiverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells.Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer.An integrative CGH, MSI and candidate genes methylation analysis of colorectal tumors.Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung.SegCorr a statistical procedure for the detection of genomic regions of correlated expression.Incorporating VEGF-targeted therapy in advanced urothelial cancer.Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11-p12-amplified breast carcinomas.Tissue microarrays for predictive molecular pathology.Signaling by FGFR1 amplification mutantsRab coupling protein mediated endosomal recycling of N-cadherin influences cell motility.Silencing of histone methyltransferase NSD3 reduces cell viability in osteosarcoma with induction of apoptosis.
P2860
Q24337453-4F703361-979E-49B7-944D-911053819732Q24530598-8106E693-626F-4BA4-A079-832CF411DF31Q24670213-B8E58031-F26D-473A-9CA3-164136087D78Q26998955-57344800-6100-4E5C-BB45-D6A0D522AC53Q27026323-7CAA373F-2D53-4109-B93F-F56EC900EA1BQ27851654-9E5C1FC8-3CCF-4F67-A516-0BA41A6BCEBAQ28079309-5712C98E-F2D1-46C9-B2C3-67695DB77656Q28252569-DC59A25E-8B42-41D9-85B9-ED8A2E8A8EE3Q30489312-D4112B11-F09D-4CB0-917D-5F47C78D468BQ33733751-A1BC47D9-5367-48C1-97E9-7391DF29B959Q33826132-D55CBEC2-767A-4D7F-8DD9-6245AD49CAFFQ34048738-50D3E67E-BD94-4EEA-A765-3A0E6FBA2334Q34395643-8630D5BF-EFC0-4104-98F7-C3C6A249B454Q35083274-BE1E94A5-0337-44D0-8EC1-F40BF98CADD7Q35206634-DE937F6B-2B95-454A-A1C8-1C26AADCB4F1Q35689819-70B67EDB-8186-4DB7-A710-75FD028EF61AQ35881055-5F1AD62A-E399-41B3-AEC8-47A2F97B2F56Q36390216-94D0CCDB-3E91-453F-AE29-FCA80E0C55DDQ36605057-80CF730C-C42E-4582-9C19-E9D7B1137FBEQ37331829-B10C36E8-C5F9-4F53-83FA-61B0370E0D7CQ37520573-EC85788C-29A3-49C7-B9B0-FD23D12FEA8AQ38390024-B4F581C3-76CE-4363-9B7A-03B8D4448738Q38683767-F764B486-2C3F-4B5E-84B1-43DC622E7187Q38756931-2877259F-2F48-4415-963E-370D50BF20B7Q40058161-29F79759-746E-4C06-842F-4A48E549E62DQ43011455-B4621224-E534-4B54-ACED-E9CBBC04BCD8Q45314361-DB1865DA-25DE-4C77-A997-89CFA2D52478Q47093915-913DB443-D4FD-41AF-8E73-8515CB7D84D2Q47681326-0384C805-974D-4F4C-8914-505E4106CD16
P2860
High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer
description
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im Juni 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2001/06/01)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd op 2001/06/01)
@nl
наукова стаття, опублікована в червні 2001
@uk
مقالة علمية (نشرت في يونيو 2001)
@ar
name
High-throughput tissue microar ...... ions in urinary bladder cancer
@ast
High-throughput tissue microar ...... ions in urinary bladder cancer
@en
High-throughput tissue microar ...... ions in urinary bladder cancer
@nl
type
label
High-throughput tissue microar ...... ions in urinary bladder cancer
@ast
High-throughput tissue microar ...... ions in urinary bladder cancer
@en
High-throughput tissue microar ...... ions in urinary bladder cancer
@nl
prefLabel
High-throughput tissue microar ...... ions in urinary bladder cancer
@ast
High-throughput tissue microar ...... ions in urinary bladder cancer
@en
High-throughput tissue microar ...... ions in urinary bladder cancer
@nl
P2093
P1433
P1476
High-throughput tissue microar ...... ions in urinary bladder cancer
@en
P2093
A. Schönenberger
D. Ackermann
H. Knönagel
J. Bruderer
J. L. Fehr
P304
P407
P577
2001-06-01T00:00:00Z